Back

Physioxia Reprograms Glioblastoma Cells Enhancing Migration and Altering Therapeutic Sensitivity

Hockaden, N.; OHerron, E.; Zhou, D.; Heffernan, M.; Cooper, S.; Richardson, A.

2026-07-10 cancer biology
10.64898/2026.07.05.736632 bioRxiv
Show abstract

Background/ObjectivesGlioblastoma is an aggressive primary brain tumor that develops within a chronically low-oxygen microenvironment, yet most preclinical studies are performed under atmospheric oxygen conditions that poorly reflect in vivo physiology. This study investigated how sustained culture under physiological oxygen tension (physioxia; 5% O{square}) influences glioblastoma cell behavior, signaling, and therapeutic response. MethodsMultiple patient-derived glioblastoma models were cultured under normoxia (21% O{square}) or sustained physioxia (5% O{square}) for at least seven days before experimentation. Cell migration, proliferation, cell cycle distribution, expression of the epithelial-to-mesenchymal transition-associated transcription factor Slug (SNAI2), PDGFR{beta}-associated signaling, and sensitivity to 5-fluorouracil were evaluated using transwell migration assays, cell counting, flow cytometry, RT-qPCR, immunoblotting, and BrdU incorporation assays. Additional patient-derived cultures established and maintained continuously under physioxia were used to examine the effects of oxygen history. ResultsSustained physioxia consistently increased migration across all glioblastoma models while reducing proliferation in normoxia-adapted cell lines through increased G0/G1 cell cycle arrest. Physioxia significantly increased Slug expression in all models and enhanced PDGFR{beta}, AKT, and ERK phosphorylation in a cell line-dependent manner. Therapeutic sensitivity to 5-fluorouracil was also altered, with physioxia conferring increased resistance in selected glioblastoma models but not universally. Patient-derived cultures maintained continuously under physioxia retained enhanced migratory capacity and exhibited increased proliferation compared with normoxia, indicating that prior oxygen exposure influences proliferative responses while the pro-migratory phenotype remains conserved. ConclusionsPhysiological oxygen tension is a major regulator of glioblastoma cell behavior, influencing migration, proliferation, signaling, and therapeutic response. These findings demonstrate that conventional normoxic culture conditions can obscure biologically relevant phenotypes and support incorporating physioxia into experimental design to improve the physiological and translational relevance of preclinical glioblastoma research.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 13%
13.7%
2
Neuro-Oncology
36 papers in training set
Top 0.1%
12.7%
3
Journal of Neuro-Oncology
10 papers in training set
Top 0.1%
10.4%
4
Neuro-Oncology Advances
25 papers in training set
Top 0.1%
8.4%
5
BMC Cancer
67 papers in training set
Top 0.4%
4.6%
6
Scientific Reports
3612 papers in training set
Top 21%
4.6%
50% of probability mass above
7
Cancers
213 papers in training set
Top 2%
3.4%
8
Neoplasia
23 papers in training set
Top 0.1%
3.0%
9
Acta Neuropathologica Communications
89 papers in training set
Top 0.7%
2.9%
10
FEBS Open Bio
31 papers in training set
Top 0.2%
2.1%
11
Frontiers in Oncology
103 papers in training set
Top 2%
2.0%
12
Frontiers in Bioengineering and Biotechnology
98 papers in training set
Top 1.0%
1.8%
13
Journal of Neuroinflammation
61 papers in training set
Top 0.8%
1.6%
14
JCI Insight
277 papers in training set
Top 5%
1.2%
15
Cancer Research Communications
51 papers in training set
Top 1%
1.2%
16
Biomedicines
67 papers in training set
Top 2%
1.1%
17
Cell Communication and Signaling
51 papers in training set
Top 1%
1.0%
18
Oncotarget
18 papers in training set
Top 0.4%
0.9%
19
Cancer Research
130 papers in training set
Top 3%
0.9%
20
iScience
1154 papers in training set
Top 38%
0.7%
21
Journal of The Royal Society Interface
235 papers in training set
Top 4%
0.7%
22
Experimental Cell Research
28 papers in training set
Top 0.9%
0.5%
23
ASN Neuro
10 papers in training set
Top 0.1%
0.5%
24
mSphere
302 papers in training set
Top 8%
0.5%
25
Biomolecules
100 papers in training set
Top 4%
0.5%
26
International Journal of Cancer
49 papers in training set
Top 2%
0.5%
27
Frontiers in Molecular Biosciences
102 papers in training set
Top 3%
0.5%
28
Molecular Cancer Therapeutics
40 papers in training set
Top 1%
0.5%
29
Molecular Cancer Research
49 papers in training set
Top 2%
0.5%
30
PeerJ
308 papers in training set
Top 14%
0.5%